WENTWORTH KORY JAMES Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
37
Insider Sells Sum
$1.81M

Insider Activity of WENTWORTH KORY JAMES

According to the SEC Form 4 filings, WENTWORTH KORY JAMES, being in a position of

  1. Chief Financial Officer at Entrada Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 35875 shares for $433,577,
    over all time since 2022-08-16, has bought 0 shares, and sold 136781 share for $2.02M.

Biography of WENTWORTH KORY JAMES

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $433,5775100

Comparison of Insiders on Amount of Buys and Sells

2026-04-01SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
2,500
0.0063%
$12.95$32,375-48.89%
2026-03-10SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
11,388
0.0305%
$13.02$148,216-46.97%
2026-03-09SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
5,089
0.0137%
$13.00$66,163-44.88%
2026-03-04SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
7,988
0.0205%
$12.25$97,892-43.68%
2025-11-21SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
8,910
0.023%
$9.98$88,932-24.83%
2025-03-17SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
1,784
0.0047%
$10.67$19,035-25.9%
2024-12-02SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
5,000
0.0131%
$20.00$99,978-60.58%
2024-11-29SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
1,000
0.0027%
$19.97$19,970-59.73%
2024-11-11SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
8,637
0.0233%
$19.98$172,562-59.7%
2024-09-09SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
3,195
0.0086%
$14.97$47,832-28.24%
2024-07-08SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
1,758
0.0055%
$14.95$26,282-6.37%
2024-03-06SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
4,086
0.0123%
$12.31$50,285+23.12%
2023-12-26SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
94
0.0003%
$16.67$1,567-7.94%
2023-12-22SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
10,206
0.029%
$15.69$160,124-7.26%
2023-12-21SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
2,200
0.0068%
$15.07$33,155+3.93%
2023-09-06SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
950
0.0028%
$13.48$12,806+6.16%
2023-07-11SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
3,884
0.012%
$18.00$69,904-18.18%
2023-07-10SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
6,116
0.0189%
$17.98$109,958-18.05%
2023-06-21SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
8,907
0.0276%
$15.17$135,129-2.44%
2023-06-21SaleEntrada Therapeutics, Inc.
TRDA
Chief Financial Officer
17,500
0.0536%
$15.01$262,648-2.44%
Total: 32
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.